Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.00    1.00 (1.43%)
Bid:
70.00
Ask:
72.00
Spread: 2.00 (2.857%)
Market Cap: £323.13m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Avacta Group News

Avacta joint venture with Daewoong raises $7.3m in series A funding
1 Feb 2021

Avacta joint venture with Daewoong raises $7.3m in series A funding

(Sharecast News) - Biotherapeutics developer Avacta Group announced on Monday that its joint venture with Daewoong Pharmaceutical, AffyXell Therapeuti...

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test
28 Jan 2021

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma
7 Jan 2021

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

Avacta enters licence agreement with Point Biopharma
7 Jan 2021

Avacta enters licence agreement with Point Biopharma

(Sharecast News) - Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Th...

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost
23 Dec 2020

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Avacta submits clinical trial application for 'AVA6000' prodrug
23 Dec 2020

Avacta submits clinical trial application for 'AVA6000' prodrug

(Sharecast News) - Cancer therapy developer Avacta Group has submitted a clinical trial application in the UK for a phase 1 first-in-human open label ...

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain
21 Dec 2020

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Avacta enters 'Affimer' licensing deal with Astrea Bioseparations
21 Dec 2020

Avacta enters 'Affimer' licensing deal with Astrea Bioseparations

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a licensing agreement with Astrea Bioseparations, it annou...